Literature DB >> 13612207

Defibrination syndrome in pregnancy: value of various diagnostic tests.

A A SHARP, B HOWIE, R BIGGS, D T METHUEN.   

Abstract

Entities:  

Keywords:  AFIBRINOGENEMIA/in pregnancy; PREGNANCY/complications

Mesh:

Year:  1958        PMID: 13612207     DOI: 10.1016/s0140-6736(58)90579-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

1.  HAEMATOLOGY AND THE EXTRACORPOREAL CIRCULATION.

Authors:  A A SHARP; M J EGGLETON
Journal:  J Clin Pathol       Date:  1963-11       Impact factor: 3.411

2.  [New light on the "defibrination syndrome"].

Authors:  H STIRNEMANN; L BUECHLER
Journal:  Klin Wochenschr       Date:  1961-12-15

3.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

4.  Recurrent blood-coagulation failure in pregnancy with birth of a live child.

Authors:  J S SCOTT; J G READER
Journal:  Br Med J       Date:  1962-01-20

5.  A suggested schedule for the rapid investigation of acute haemostatic failure.

Authors:  G I INGRAM
Journal:  J Clin Pathol       Date:  1961-07       Impact factor: 3.411

6.  A rapid "side-room" method for the determination of plasma fibrinogen concentration as fibrin.

Authors:  G I INGRAM; M O MATCHETT
Journal:  J Clin Pathol       Date:  1960-11       Impact factor: 3.411

7.  Hypofibrinogenaemia as a cause of bleeding in chronic myeloid leukaemia.

Authors:  J A Whittaker; M Khurshid
Journal:  Br Med J       Date:  1975-03-01

8.  Prolonged partial left heart bypass in sheep: successful use of a new type of pump.

Authors:  L J Temple; H E Ritchie; J T Wright; J Koziell
Journal:  Thorax       Date:  1971-09       Impact factor: 9.139

9.  A haemorrhagic disorder in pregnancy due to an "anticoagulant" preventing the conversion of fibrinogen to fibrin.

Authors:  S J BAKER; E JACOB
Journal:  J Clin Pathol       Date:  1960-05       Impact factor: 3.411

10.  Defibrination syndrome with defective thrombinfibrinogen reaction reversible by protamine.

Authors:  A L Bloom; N Campbell
Journal:  J Clin Pathol       Date:  1965-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.